Pettie, Chapter 7 Trustee for the Estate of Medcro v. Medcross Imaging, LLC

CourtUnited States Bankruptcy Court, N.D. Georgia
DecidedJune 21, 2023
Docket22-05013
StatusUnknown

This text of Pettie, Chapter 7 Trustee for the Estate of Medcro v. Medcross Imaging, LLC (Pettie, Chapter 7 Trustee for the Estate of Medcro v. Medcross Imaging, LLC) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pettie, Chapter 7 Trustee for the Estate of Medcro v. Medcross Imaging, LLC, (Ga. 2023).

Opinion

RUPI ep Cc: % a oP □

2, oe Berge | Oh ee, IT IS ORDERED as set forth below: bisreics

Date: June 20, 2023 Ly \/ Barbara Ellis-Monro U.S. Bankruptcy Court Judge

UNITED STATES BANKRUPTCY COURT NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION IN RE: Medcross Imaging, LLC, CASE NO. 20-61522-BEM Debtor. CHAPTER 7

Jason L. Pettie, Chapter 7 Trustee for the Estate of Medcross Imaging, LLC, Plaintiff, ADVERSARY PROCEEDING NO. V. 22-05013-BEM Medcross Imaging, LLC, et al., Defendants. ORDER This matter is before the Court on Plaintiff's Motion to Reopen Discovery, filed on May 29, 2023 (the “Motion”). [Doc. 72]. Defendants Honey Creek Diagnostics, LP (“Honey

Creek”) and Pankesh Kadam (“Kadam”) filed responses in opposition to the Motion. [Docs. 73, 74]. I. Procedural History This adversary proceeding commenced on January 20, 2022, when Plaintiff filed his complaint seeking to avoid alleged fraudulent transfers and unauthorized post-petition transfers

by Defendants. [Doc. 1]. Despite Plaintiff’s failure to file a certificate of service of the summons and complaint, Defendants Honey Creek, Kadam, Amscan Radiology and Imaging Solutions, Inc. (“Amscan Radiology”), APS Services, Inc. (“APS”), and FTC Capital Partners, LLC (“FTC Capital”) filed answers on February 21, 2022. [Docs. 4, 5, 6]. Additionally, on February 21, 2022, Defendant Alka Patel (“Patel”) filed a motion to dismiss or for summary judgment [Doc. 7], and APS and FTC Capital filed a motion for summary judgment. [Doc. 8]. On March 8, 2022, Plaintiff filed an Amended Complaint [Doc. 17] and a motion to defer consideration or deny the pending motions to dismiss and for summary judgment. [Doc. 19]. However, because there was no evidence of service of the original complaint and summons

as required by Federal Rule of Bankruptcy Procedure (“Bankruptcy Rule” or “Rule”) 7004, the Court entered an order on March 14, 2022, (the “March 14 Order”) granting Plaintiff’s motion to defer consideration of FTC Capital and APS’s summary judgment motion, granting Plaintiff leave to file the amended complaint and requiring Plaintiff to obtain an alias summons, perfect service of the amended complaint and file certification thereof. The Court further directed Patel to file an answer to the amended complaint within the time required by the applicable Bankruptcy Rules and provided for Plaintiff to serve limited discovery on FTC Capital and APS for the purpose of identifying post-petition transfers. The March 14 Order further stated that the timelines in the Bankruptcy Rules and the Local Rules for the Bankruptcy Court for the Northern District of Georgia (the “BLRs”) would govern discovery and the filing of dispositive motions related to the amended complaint. [Doc. 26]. Kadam, Amscan Radiology, Honey Creek, Patel, APS, and FTC Capital filed answers to Plaintiff’s amended complaint on March 28, 2022. [Docs. 32, 33, 34]. As a result of the filing of the answers and pursuant to the Court’s March 14 Order and B.L.R. 7016(a)(2), (b)(2),

discovery was set to commence on April 18, 2022, and conclude on July 18, 2022. Debtor- Defendant MedCross Imaging, LLC (“MedCross”) did not file an answer or other response to the original complaint or the amended complaint. Plaintiff then filed a Motion for Dismissal without Prejudice (“Plaintiff’s First Motion to Dismiss”) of Plaintiff’s claims against APS, FTC Capital, and Patel on May 9, 2022. [Doc. 37]. Defendants APS, FTC Capital, and Patel responded to Plaintiff’s First Motion to Dismiss seeking dismissal of all claims against them with prejudice or in the alternative dismissal conditioned upon payment to them of their legal fees and expenses. [Doc. 40]. APS, FTC Capital, and Patel reasoned dismissal with prejudice was proper under Fed. R. Civ. P. 41(a)(2) because the

Trustee had no factual basis for his claims in violation of Bankruptcy Rule 9011. [Id.]; see Fed. R. Bankr. P. 7041. Plaintiff replied to APS, FTC Capital, and Patel’s response asserting that the Defendants had not shown that dismissal with prejudice was justified. [Doc. 41]. The Court granted Plaintiff’s motion to dismiss to the extent that it sought to dismiss APS, FTC Capital, and Patel on July 21, 2022; however, due to Plaintiff’s lack of diligence in prosecuting the case, namely that no motion to compel or any other action was taken to obtain the documents that could substantiate Plaintiff’s claims against the Defendants, the Defendants were dismissed with prejudice. [Docs. 40, 45]. On August 2, 2022, Plaintiff served discovery on Honey Creek, MedCross, and Amscan Radiology. [Docs. 47-49]. Thereafter, this proceeding remained stagnant without any action by Plaintiff until the Court, sua sponte, ordered a status conference to be held on January 10, 2023. [Doc. 55]. At the status conference, Plaintiff made an oral motion to reopen discovery to which Honey Creek objected and that was denied by the Court. [Doc. 57]; see B.L.R. 9003-2.

In the Court’s January 17, 2023, order the parties were directed to file dispositive motions within 30 days and to file a joint pre-trial order within the later of 45 days of the entry of the order or 15 days after the Court ruled on any dispositive motions. [Id.]. No dispositive motions or pre-trial order were filed within the deadlines established in the order. As a result, the Court entered an order directing the parties to meet and confer and to submit a consolidated pre-trial order within 21 days. [Doc. 59]. On March 27, 2023, Counsel for Plaintiff uploaded a proposed pre-trial order to the Court’s e-orders system that was signed off by Counsel for Plaintiff, Counsel for Honey Creek, and Counsel for Amscan Radiology. The Court did not sign the proposed pre-trial order because

it (i) sought to allow Plaintiff to request documents for production at trial, (ii) was not in the form required by B.L.R. 7016-2, (iii) contained argument as to counts of the amended complaint against defendants that had been dismissed, (iv) did not contain stipulated facts many of which were apparent from the amended complaint and Answers, and (v) was not joined by Kadam. Thus, the Court scheduled a pre-trial conference for May 9, 2023, to discuss the proposed order. [Doc. 63]. Meanwhile, Amscan Radiology filed a Motion to Dismiss Amended Adversary and Motion for Judgment on the Pleadings (“Amscan Radiology’s Motion to Dismiss”) [Doc. 62], which was then followed by Plaintiff’s Motion for Dismissal Without Prejudice of Plaintiff’s claims against Amscan Radiology. [Doc. 65]. After the May 9, 2023, pre-trial conference, the Court entered an order requiring, (i) Plaintiff’s counsel to determine what documents he still needed from Defendants, (ii) the parties to amend the proposed pre-trial order to comply with the BLRs, (iii) the parties to discuss the remaining issues to be tried and how they could be streamlined, and (iv) the pre-trial conference be continued to May 18, 2023. [Doc. 66]. After the May 18, 2023, conference, the Court entered

a further order setting deadlines for filing motions to reopen discovery and for Defendants to submit to Plaintiff’s Counsel changes for a proposed pre-trial order. [Doc. 69]. The Court also entered an order granting Plaintiff’s motion to dismiss Amscan Radiology without prejudice and denied Amscan Radiology’s Motion to Dismiss as moot. [Doc. 68]. Thus, the remaining Defendants are MedCross, Honey Creek, and Kadam (the “Remaining Defendants”). II.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Howard Gregory Cordell v. Pacific Indemnity Co.
335 F. App'x 956 (Eleventh Circuit, 2009)
Cheney v. Anchor Glass Container Corp.
71 F.3d 848 (Eleventh Circuit, 1996)
Advanced Estimating System, Inc. v. Riney
77 F.3d 1322 (Eleventh Circuit, 1996)
Orrin Monroe Corwin v. Walt Disney Company
475 F.3d 1239 (Eleventh Circuit, 2007)
Martha Locke v. SunTrust Bank
484 F.3d 1343 (Eleventh Circuit, 2007)
Oravec v. Sunny Isles Luxury Ventures, L.C.
527 F.3d 1218 (Eleventh Circuit, 2008)
Fisher Island Limited v. Fisher Island Investments, Inc.
518 F. App'x 663 (Eleventh Circuit, 2013)
David S. Yang v. Bullock Financial Group, Inc.
435 F. App'x 842 (Eleventh Circuit, 2011)
EarthCam, Inc. v. OxBlue Corporation
703 F. App'x 803 (Eleventh Circuit, 2017)
Ashmore v. Secretary, Department of Transportation
503 F. App'x 683 (Eleventh Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Pettie, Chapter 7 Trustee for the Estate of Medcro v. Medcross Imaging, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pettie-chapter-7-trustee-for-the-estate-of-medcro-v-medcross-imaging-llc-ganb-2023.